Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Multi-Factor Investor model based on the published strategy of ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

However, on the same day, Jefferies maintained a Buy rating on Amgen (NASDAQ: AMGN). Based on Amgen’s latest earnings release for the quarter ending September 30, the company reported a quarterly ...

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of ...

However, today, Truist Financial assigned a Hold rating to Amgen (NASDAQ: AMGN). Based on Amgen’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Amgen (NASDAQ:AMGN – Free Report) had its target price cut by UBS Group from $335.00 to $326.00 in a report released on Thursday, Benzinga reports. They currently have a neutral rating on the medical ...

Analysts on Wall Street project that Amgen (AMGN) will announce quarterly earnings of $5.11 per share in its forthcoming report, representing an increase of 3% year over year. Revenues are ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharma stocks. Healthcare takes the concept of ‘defensive’ further than almost any ...

UBS lowered the firm’s price target on Amgen (AMGN) to $326 from $335. Amgen reported in-line topline sales for Q3, with most products as expected, while weaker sales for Enbrel, Prolia ...

Amgen's financial performance shows resilience amidst macroeconomic challenges. Amgen Inc (NASDAQ:AMGN), a global biotechnology leader, released its 10-Q filing on October 31, 2024, offering a ...